Literature DB >> 28450959

Changes in liver stiffness and its associated factors during oral antiviral therapy in Chinese patients with chronic hepatitis B.

Xu Li1, Qinglong Jin1, Hong Zhang2, Xue Jing3, Zhongyang Ding1, Hongjie Zhou1, Zetian Zhang1, Dongqing Yan1, Dongmei Li1, Pujun Gao1, Junqi Niu1.   

Abstract

The present study aimed to assess improvements in liver stiffness determined by transient elastography and associated factors in Chinese patients with chronic hepatitis B (CHB) during long-term treatment with oral antiviral drugs. A total of 334 consecutive Chinese patients with CHB who underwent oral antiviral therapy and received at least two liver stiffness measurements (LSMs) at the First Hospital of Jilin University (Changchun, China) from December 2012 to February 2015 were enrolled in the present study. The cohort included 201 patients without liver cirrhosis (group 0) and 133 patients with liver cirrhosis (group 1). Each patient was subjected to LSM twice with an interval of 6 months. The mean initial liver stiffness values were 14.01±9.37 and 21.59±10.25 kPa for patients in group 0 and group 1, respectively (P<0.001). Multivariate analysis revealed that higher aspartate aminotransferase and lower alanine aminotransferase levels at baseline as well as higher α-fetoprotein levels at follow-up (24 weeks) were associated with a greater decline of liver stiffness in group 0. Furthermore, a higher liver stiffness at baseline and a longer course of antiviral therapy prior to the initial LSM were significantly correlated with a reduction of liver stiffness, whereas higher total bilirubin levels at follow-up contributed to increased liver stiffness in group 1. In conclusion, LSM at the beginning and the end of a 24-week observation period showed that antiviral drug therapy significantly improved in group 1, while a marked decreasing trend was also observed in group 0. In group 0, the reduction of liver stiffness was correlated with liver inflammation, whereas in group 1, it was correlated with the treatment duration prior to the initial LSM and serum levels of hepatitis B virus DNA. Furthermore, a higher liver stiffness at baseline was associated with a greater reduction of liver stiffness in each group.

Entities:  

Keywords:  anti-viral drug; chronic hepatitis B; liver fibrosis

Year:  2017        PMID: 28450959      PMCID: PMC5403208          DOI: 10.3892/etm.2017.4065

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  16 in total

1.  On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients.

Authors:  Grace Lai-Hung Wong; Vincent Wai-Sun Wong; Paul Cheung-Lung Choi; Anthony Wing-Hung Chan; Angel Mei-Ling Chim; Karen Ka-Lam Yiu; Shirley Hoi-Ting Chu; Francis Ka-Leung Chan; Joseph Jao-Yao Sung; Henry Lik-Yuen Chan
Journal:  Antivir Ther       Date:  2011

2.  Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

Authors:  Patrick Marcellin; Edward Gane; Maria Buti; Nezam Afdhal; William Sievert; Ira M Jacobson; Mary Kay Washington; George Germanidis; John F Flaherty; Raul Aguilar Schall; Jeffrey D Bornstein; Kathryn M Kitrinos; G Mani Subramanian; John G McHutchison; E Jenny Heathcote
Journal:  Lancet       Date:  2012-12-10       Impact factor: 79.321

3.  Reduction of liver stiffness by antiviral therapy in chronic hepatitis B.

Authors:  Keisuke Osakabe; Naohiro Ichino; Toru Nishikawa; Hiroko Sugiyama; Miho Kato; Shiho Kitahara; Senju Hashimoto; Naoto Kawabe; Masao Harata; Yoshifumi Nitta; Michihito Murao; Takuji Nakano; Hiroaki Shimazaki; Yuko Arima; Koji Suzuki; Kentaro Yoshioka
Journal:  J Gastroenterol       Date:  2011-08-06       Impact factor: 7.527

4.  Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B.

Authors:  Eugene R Schiff; Samuel S Lee; You-Chen Chao; Seung Kew Yoon; Fernando Bessone; Shun-Sheng Wu; Wieslaw Kryczka; Yoav Lurie; Adrian Gadano; George Kitis; Suzanne Beebe; Dong Xu; Hong Tang; Uchenna Iloeje
Journal:  Clin Gastroenterol Hepatol       Date:  2010-12-08       Impact factor: 11.382

5.  Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.

Authors:  Nathalie Ganne-Carrié; Marianne Ziol; Victor de Ledinghen; Catherine Douvin; Patrick Marcellin; Laurent Castera; Daniel Dhumeaux; Jean-Claude Trinchet; Michel Beaugrand
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

Review 6.  Clinical trial results of new therapies for HBV: implications for treatment guidelines.

Authors:  Robert G Gish
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

Review 7.  Non-invasive diagnosis of hepatitis B virus-related cirrhosis.

Authors:  Sangheun Lee; Do Young Kim
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

8.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

Authors:  Laurent Sandrin; Bertrand Fourquet; Jean-Michel Hasquenoph; Sylvain Yon; Céline Fournier; Frédéric Mal; Christos Christidis; Marianne Ziol; Bruno Poulet; Farad Kazemi; Michel Beaugrand; Robert Palau
Journal:  Ultrasound Med Biol       Date:  2003-12       Impact factor: 2.998

9.  Sustained virological response following HCV therapy is associated with non-progression of liver fibrosis in HCV/HIV-coinfected patients.

Authors:  Pablo Barreiro; Pablo Labarga; Luz Martín-Carbonero; Aranzazu Amor; Andrés Ruiz-Sancho; Carol Castellares; Juan González-Lahoz; Vincent Soriano
Journal:  Antivir Ther       Date:  2006

Review 10.  Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.

Authors:  Tung-Hung Su; Jia-Horng Kao; Chun-Jen Liu
Journal:  Int J Mol Sci       Date:  2014-06-12       Impact factor: 5.923

View more
  2 in total

1.  Influence of Gender and Reproductive Factors on Liver Fibrosis in Patients With Chronic Hepatitis B Infection.

Authors:  Ming Xiong; Junying Li; Shuling Yang; Fansen Zeng; Yali Ji; Jiang Liu; Qiaoping Wu; Qingjun He; Ronglong Jiang; Fuyuan Zhou; Weiqun Wen; Jinjun Chen; Jinlin Hou
Journal:  Clin Transl Gastroenterol       Date:  2019-10       Impact factor: 4.488

2.  Cutoff Values of Acoustic Radiation Force Impulse Two-Location Measurements in Different Etiologies of Liver Fibrosis.

Authors:  Tse-Hwa Hsu; Po-Hsiang Tsui; Wan-Ting Yu; Shiu-Feng Huang; Jennifer Tai; Yung-Liang Wan; Dar-In Tai
Journal:  J Med Ultrasound       Date:  2019-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.